Mediastinal cancer develops in the region between the lungs known as the mediastinum and can affect lymph nodes, the heart, and other organs in this area. Mediastinal cancer can manifest through various symptoms depending on the type of tumor and its location. Some mediastinal cancer symptoms may include chest pain, difficulty breathing, and coughing. While a mediastinal cancer diagnosis can be frightening, patients should feel hopeful knowing there are more effective and precise treatment options than ever before. Top cancer centres harness cutting-edge technologies and provide compassionate, personalised care to help people with mediastinal tumours achieve the best possible outcomes.
Thymomas are the most frequently occurring tumours in the mediastinum, the area between the lungs, and they account for up to 70% of all mediastinal cancer cases. The good news is that thymomas are highly treatable. The standard approach involves a combination of surgery to remove the tumour and any affected surrounding tissue, followed by radiation therapy to eradicate any remaining cancer cells. In some instances, chemotherapy may be added to surgery and radiation to further reduce the chance of the cancer coming back or spreading.
Lymphomas, cancers of the lymphatic system, are another type of tumour that can arise in the mediastinum. These can be classified as either Hodgkin or non-Hodgkin lymphoma. Patients may experience mediastinal lymph nodes cancer symptoms such as swelling of the lymph nodes, fever, and weight loss. Treatment for mediastinal lymphoma typically involves a combination of chemotherapy, radiation therapy, and surgery. The specific treatment plan depends on the lymphoma subtype and stage.
Neurogenic tumours affect the nervous system and can develop in the mediastinum. Treatment for these tumours usually involves surgical removal followed by radiation therapy to destroy any residual cancer cells in the region.
The causes of mediastinal mass vary depending on the type of tumour present. Thymomas, lymphomas, and neurogenic tumours may all arise in the mediastinum due to genetic factors, environmental exposures, or a weakened immune system. Understanding the underlying causes can help in developing an effective treatment strategy.
Mediastinal cancers are a complex group of diseases that require a tailored, multidisciplinary treatment approach. The optimal therapy plan depends on several factors, including the type of mediastinal tumour, its size and location, the extent of the disease, and the patient’s overall health.
Treatment options for mediastinal cancer include:
The mediastinal cancer prognosis depends on the type of tumour, stage at diagnosis, and the patient’s overall health. Early detection and advanced treatments have significantly improved survival rates. Patients with localized tumours generally have a better prognosis than those with metastatic disease.
Mediastinal cancer treatment is a complex and multi-faceted process, and patients need to discuss their options with their healthcare team to determine the best plan for them. Proton therapy is an excellent choice that can be used to effectively target and treat tumours, with fewer side effects and a lower dose of radiation administered to the patient.
APCC offers personalised care and support for those undergoing treatment, making it an excellent choice for those seeking the best treatments. With access to cutting-edge technology, advanced treatments, and comprehensive patient care, APCC provides world-class care that allows patients to receive the best possible outcome from their treatment.
Copyright © 2024 Apollo Proton Cancer Centre. All Rights Reserved